LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
363,214,619
Total 13F shares
121,559,642
Share change
-321,051
Total reported value
$478,894,149
Put/Call ratio
133%
Price per share
$3.94
Number of holders
108
Value change
-$1,466,109
Number of buys
58
Number of sells
39

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q4 2021

As of 31 Dec 2021, LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) was held by 108 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 121,559,642 shares. The largest 10 holders included Artal Group S.A., BVF INC/IL, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, D. E. Shaw & Co., Inc., NEA Management Company, LLC, PINNACLE ASSOCIATES LTD, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 108 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.